Skip to main content
. Author manuscript; available in PMC: 2016 Dec 22.
Published in final edited form as: Annu Rev Virol. 2015 Sep 25;2(1):379–401. doi: 10.1146/annurev-virology-100114-055141

Figure 4.

Figure 4

Fundamentals of tissue- or disease-targeted virus-based nanoparticles (VNPs). Targeting ligands are presented on the exterior of the VNP to facilitate active cell-specific surface binding and/or receptor-mediated endocytosis. Additional unique factors, such as the enhanced permeability and retention (EPR) effect in tumor masses or VNP shape, can further aid in passive localization.